Recombinant MS4A1 (Rituximab Biosimilar) 抗体
Research Grade
适用: 人
ELISA
宿主: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- 抗原 See all MS4A1 (Rituximab Biosimilar) products
- MS4A1 (Rituximab Biosimilar)
- 抗体类型
- Recombinant Antibody
-
适用
- 人
-
宿主
-
Mammalian Cells
- Expression System
- Mammalian cells
-
克隆类型
- 单克隆
-
标记
- This MS4A1 (Rituximab Biosimilar) antibody is un-conjugated
-
应用范围
- ELISA
- 原理
- Rituximab Biosimilar - Anti-MS4A1 mAb
- 产品特性
- Antibody Type: IgG1
- 纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
- 质量等级
- Research Grade
- 亚型
- IgG1
-
anti-MS4A1 (Rituximab Biosimilar) antibody
适用: 人, Cynomolgus, 猕猴 FACS 宿主: 兔 Monoclonal 10F381 unconjugated Recombinant Antibody
-
- 限制
- 仅限研究用
-
- 缓冲液
- PBS pH 7.5
- 储存条件
- 4 °C,-20 °C
- 储存方法
- 4°C for short term, -20°C for long term
-
- 抗原
- MS4A1 (Rituximab Biosimilar)
- Abstract
- MS4A1 (Rituximab Biosimilar) 产品
- 别名
- B1 antibody, Bp35 antibody, CD20 antibody, CVID5 antibody, LEU-16 antibody, MS4A2 antibody, S7 antibody, membrane spanning 4-domains A1 antibody, MS4A1 antibody
- 物质类
- Biosimilar
- 背景
-
Rituximab
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. When it binds to this protein it triggers cell death. Rituximab is a medication used to treat certain autoimmune diseases and types of cancer. It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and EpsteinBarr virus-positive mucocutaneous ulcers.
-
You are here:
